Glis1, a unique pro-reprogramming factor, may facilitate clinical applications of iPSC technology

 Abstract

Comment on: Maekawa M, et al. Nature 2011; 474:225-9.

Full Text Options
Article
Metrics
 Share
 Info
Pages
3613 - 3614
doi
10.4161/cc.10.21.17834
Type
Editorials: Cell Cycle Features
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Glis1, a unique pro-reprogramming factor, may facilitate clinical applications of iPSC technology